BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 3669762)

  • 21. A prospective multicenter trial with human recombinant alpha 2c-interferon in hairy cell leukemia before and after splenectomy.
    Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
    Leukemia; 1987 Apr; 1(4):337-40. PubMed ID: 3669759
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Primary treatment of hairy cell leukemia with low-dose human recombinant interferon-alpha-2c (Hr-IFn alpha 2c) in comparison with therapy following splenectomy. Interferon (IFn-alpha 2c) in HCL before or after splenectomy].
    Pralle H; Zwingers T; Boedewadt S; Bross K; Dörken B; Gamm H; Ho AD; Parwaresch RM; Schmitz N; Papendick U
    Onkologie; 1987 Feb; 10(1):5-10. PubMed ID: 3295625
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hyperphosphorylation of CD20 in hairy cells. Alteration by low molecular weight B cell growth factor and IFN-alpha.
    Genot E; Valentine MA; Degos L; Sigaux F; Kolb JP
    J Immunol; 1991 Feb; 146(3):870-8. PubMed ID: 1703183
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Combination treatment of 2-chlorodeoxyadenosine and type I interferon on hairy cell leukemia-like cells: cytotoxic effect and MHC-unrestricted killer cell regulation.
    Reiter Z; Tomson S; Ozes ON; Taylor MW
    Blood; 1993 Apr; 81(7):1699-708. PubMed ID: 8096405
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Interleukin 2 protects hairy leukemic cells from lymphokine-activated killer cell-mediated cytotoxicity.
    Reiter Z; Taylor MW
    Cancer Res; 1993 Aug; 53(15):3555-60. PubMed ID: 7687924
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Immunological recovery and dose evaluation in IFN-alpha treatment of hairy cell leukemia: analysis of leukocyte differentiation antigens, NK and 2',5'-oligoadenylate synthetase activity.
    Nielsen B; Hokland M; Justesen J; Hasselbalch H; Ellegaard J; Hokland P
    Eur J Haematol; 1989 Jan; 42(1):50-9. PubMed ID: 2914594
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Interferon alpha-2 for hairy cell leukemia: evidence for induction of RNA synthesis in hairy cells and failure to correlate enhancement of natural killer cells with elimination of hairy cells.
    Schwarzmeier JD; Schwabe M; Prischl F; Wagner L; Lion T; Micksche M; Köller U
    Eur J Haematol; 1987 Nov; 39(5):418-25. PubMed ID: 3691760
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Alpha-interferon induces remission in hairy cell leukemia without enhancement of natural killing.
    Gastl G; Aulitzky W; Leiter E; Flener R; Huber C
    Blut; 1986 May; 52(5):273-9. PubMed ID: 3635416
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Strategy for the treatment of hairy cell leukemia.
    Porzsolt F; Raghavachar A; Digel W; Raghavachar A; Bartram CR; Heimpel H
    Leukemia; 1987 Apr; 1(4):334-7. PubMed ID: 3669758
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The U.K. experience with human lymphoblastoid interferon in HCL: a report of the first 50 cases.
    Worman CP; Catovsky D; Cawley JC; Bevan PC; Bottomley JM; Nethersell AB
    Leukemia; 1987 Apr; 1(4):320-2. PubMed ID: 3669754
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Hairy cells possess more interferon receptors than other lymphoid cell types.
    Dadmarz R; Evans T; Secher D; Marshall N; Cawley JC
    Leukemia; 1987 Apr; 1(4):357-61. PubMed ID: 2959825
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Changes in hairy cells after alpha-interferon treatment as measured by flow cytometry.
    Huang AT; Mold NG
    Leukemia; 1987 Apr; 1(4):308-11. PubMed ID: 3669751
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Hairy cell leukemia: an interferon deficient disease?
    Hofmann V; Fehr J; Sauter C; Ottino J
    Cancer Treat Rev; 1985 Dec; 12 Suppl B():33-7. PubMed ID: 3833328
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Results of treating 53 hairy cell leukemia patients with alpha-interferon.
    Flandrin G; Castaigne S; Sigaux F; Degos L
    Leukemia; 1987 Apr; 1(4):326-8. PubMed ID: 3669755
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Successful treatment of T-hairy cell leukemia with lymphoblastoid-interferon.
    Rossi E; Gualandi F; Lamparelli T; Repetto M; Nocera A; Spriano M; Occhini D; Ruggeri C; Vimercati R; Damasio EE
    J Exp Pathol; 1987; 3(4):593-601. PubMed ID: 3502652
    [No Abstract]   [Full Text] [Related]  

  • 36. Alpha interferon for induction of remission in hairy-cell leukemia.
    Quesada JR; Reuben J; Manning JT; Hersh EM; Gutterman JU
    N Engl J Med; 1984 Jan; 310(1):15-8. PubMed ID: 6689734
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Results of a multicenter study of the efficacy of recombinant alpha-2c interferon in hairy cell leukemia].
    Werter MJ; Bogman MJ; Janssen JT; de Pauw BE; Haanen CA
    Ned Tijdschr Geneeskd; 1987 Nov; 131(46):2081-5. PubMed ID: 3683637
    [No Abstract]   [Full Text] [Related]  

  • 38. In vitro induction of proteins by alpha-interferon in hairy cell leukemia.
    Samuels BL; Golomb HM; Brownstein BH
    Cancer Res; 1986 Aug; 46(8):4151-5. PubMed ID: 3731082
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Hematologic and immunologic changes in hairy cell leukemia patients treated with alpha interferon.
    Turhan AG; Eaves CJ; Connors JM; Eaves AC; Karim KA; Silver KB
    J Biol Regul Homeost Agents; 1988; 2(4):157-65. PubMed ID: 2907963
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Immunomodulation by recombinant interferon-alpha 2 in a phase I trial in patients with lymphoproliferative malignancies.
    Ozer H; Gavigan M; O'Malley J; Thompson D; Dadey B; Nussbaum-Blumenson A; Snider C; Rudnick S; Ferraresi R; Norred S
    J Biol Response Mod; 1983; 2(6):499-515. PubMed ID: 6607323
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.